Axxess Pharma, Inc. Announces Major Distribution Agreement for Australia/Asia For Full Line Of TapouT® Branded Products

TORONTO, ON--(Marketwired - February 10, 2014) - Axxess Pharma Inc. (PINKSHEETS: AXXE) through its wholly-owned subsidiary AllStar Health Brands Inc. has entered into an exclusive distribution agreement with Hardcore Beverages for Australia, New Zealand, South Korea, and Indonesia with other Asian markets to be added at a later date. HardCore Beverages of Queensland, Australia has experienced first-hand the power of the TapouT® brand with the successful marketing of TapouT beverages.

Steven Ross, President of HardCore Beverages stated: “We can see from our success with the TapouT® branded beverages the power of the TapouT® brand, and our market analysis tells us these new TapouT® supplements and pain relief will do extremely well. We expect to be in over 10,000 retail outlets shortly after launch, with further expansion as we add territories. Our sponsorship of race cars and athletes has supported our marketing efforts extremely well, and we will continue these marketing initiatives with the new TapouT® product line. In addition, the demographics here in Australasia bode well for our TapouT® growth plans.”

Daniel Bagi, President of Axxess further stated, “HardCore Beverages approached us after their success with the TapouT® beverages, and had a great track record that proved they were the best fit for us in the region. We expect very strong sales in these territories and may expand the into other large Asian economies in the near future.”

About Axxess Pharma Inc.:

Axxess Pharma Inc. is a Nevada Corporation operating through its wholly-owned Canadian Subsidiary: Axxess Pharma Canada Inc., headquartered in Toronto. Axxess is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas. Axxess’s goal is to bring additional products to the market and provide new, innovative options for better health spanning areas such as high cholesterol, blood pressure, acute pain, -- to optimal health management through improved nutritional supplements.

For more information, please visit www.axxesspharmainc.com, or contact Investor Relations at (973) 351-3868.

Safe Harbor Statement

Statements about the Company’s future expectations and all other statements in this press release other than historical facts, are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.

The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words “anticipate,” “estimate,” “expect,” “intend,” “plans,” “projects,” and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.